MENU
CAPR
AS OF
Nov 13, 04:59 PM (EDT)
Price
$5.77
Change
-$0.10 (-1.70%)
Capitalization
263.8M
131 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CAPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Capricor Therapeutics (CAPR) Earnings Date & Reports

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CAPR is expected to report earnings to fall 1.44% to -53 cents per share on March 25

Capricor Therapeutics CAPR Stock Earnings Reports
Q4'25
Est.
$-0.53
Q3'25
Est.
$-0.54
Q2'25
Missed
by $0.09
Q1'25
Missed
by $0.21
Q4'24
Beat
by $0.01
The last earnings report on November 10 showed earnings per share of -54 cents, meeting the estimate of -54 cents. With 1.31M shares outstanding, the current market capitalization sits at 263.80M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CAPR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CAPR showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CAPR
A.I. Advisor
published General Information

General Information

Develops innovative products for the treatment of cardiovascular diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com